Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine’s effects or become resistant over time.
Brief admission by self-referral reduces need for emergency care in adolescents with severe self-harm
Gaining access to Brief Admission by self-referral reduced the need for emergency care in adolescents with severe self-harm.
July 3, 2023